Advances in immunotherapy for the treatment of glioblastoma

Glioblastoma (GBM) is an aggressive brain tumour, associated with extremely poor prognosis and although there have been therapeutic advances, treatment options remain limited. This review focuses on the use of immunotherapy, harnessing the power of the host’s immune system to reject cancer cells. Ke...

Descripción completa

Detalles Bibliográficos
Autores principales: Tivnan, Amanda, Heilinger, Tatjana, Lavelle, Ed C., Prehn, Jochen H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Topic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258809/
https://www.ncbi.nlm.nih.gov/pubmed/27743144
http://dx.doi.org/10.1007/s11060-016-2299-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258809/
https://www.ncbi.nlm.nih.gov/pubmed/27743144
http://dx.doi.org/10.1007/s11060-016-2299-2

Ejemplares similares